Tempest Therapeutics, Inc. Increase Decrease In Operating Lease Liability
Tempest Therapeutics, Inc. (TPST) reported Increase Decrease In Operating Lease Liability of -$581.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-13
- Tempest Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$294.00K.
- Tempest Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$287.00K.
- Tempest Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$264.00K.
- Tempest Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$258.00K.
- Tempest Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2025 was -$870.00K.
- Tempest Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2024 was -$1.10M.
- Tempest Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2023 was -$1.63M.
- Tempest Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2022 was -$1.50M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$294.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$581.00K 10-Q · filed 2026-08-13 | -$845.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.10M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$287.00K 10-Q · filed 2026-05-14 | -$551.00K derived: sum of 2 quarters · filed 2026-05-14 | -$809.00K derived: sum of 3 quarters · filed 2026-05-14 | -$1.06M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$522.00K derived: sum of 2 quarters · filed 2026-03-30 | -$774.00K derived: sum of 3 quarters · filed 2026-08-13 | -$870.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$258.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$510.00K derived: sum of 2 quarters · filed 2026-08-13 | -$606.00K 10-Q · filed 2025-11-05 | -$829.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$252.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$348.00K 10-Q · filed 2026-08-13 | -$571.00K derived: sum of 3 quarters · filed 2026-08-13 | -$939.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$96.00K 10-Q · filed 2026-05-14 | -$319.00K derived: sum of 2 quarters · filed 2026-05-14 | -$687.00K derived: sum of 3 quarters · filed 2026-05-14 | -$858.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$591.00K derived: sum of 2 quarters · filed 2026-03-30 | -$762.00K derived: sum of 3 quarters · filed 2026-03-30 | -$1.10M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$368.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$539.00K derived: sum of 2 quarters · filed 2025-11-05 | -$878.00K 10-Q · filed 2025-11-05 | -$1.27M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$510.00K 10-Q · filed 2025-08-11 | -$899.00K derived: sum of 3 quarters · filed 2025-08-11 | -$1.42M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | -$339.00K 10-Q · filed 2025-05-13 | -$728.00K derived: sum of 2 quarters · filed 2025-05-13 | -$1.25M derived: sum of 3 quarters · filed 2025-05-13 | -$1.47M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$389.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$910.00K derived: sum of 2 quarters · filed 2025-03-27 | -$1.13M derived: sum of 3 quarters · filed 2025-03-27 | -$1.63M 10-K · filed 2025-03-27 |
| 2023-09-30 | -$521.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$742.00K derived: sum of 2 quarters · filed 2024-11-12 | -$1.24M 10-Q · filed 2024-11-12 | -$1.53M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$721.00K 10-Q · filed 2024-08-08 | -$1.01M derived: sum of 3 quarters · filed 2024-08-08 | -$1.38M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$500.00K 10-Q · filed 2024-05-09 | -$791.00K derived: sum of 2 quarters · filed 2024-05-09 | -$1.16M derived: sum of 3 quarters · filed 2024-05-09 | -$1.65M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$291.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$662.00K derived: sum of 2 quarters · filed 2024-03-19 | -$1.15M derived: sum of 3 quarters · filed 2024-03-19 | -$1.50M 10-K · filed 2024-03-19 |
| 2022-09-30 | -$371.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$863.00K derived: sum of 2 quarters · filed 2023-11-08 | -$1.21M 10-Q · filed 2023-11-08 | -$1.55M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$492.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$839.00K 10-Q · filed 2023-08-10 | -$1.18M derived: sum of 3 quarters · filed 2023-08-10 | -$1.53M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$347.00K 10-Q · filed 2023-05-10 | -$688.00K derived: sum of 2 quarters · filed 2023-05-10 | -$1.04M derived: sum of 3 quarters · filed 2023-05-10 | -$1.15M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$341.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$690.00K derived: sum of 2 quarters · filed 2023-03-22 | -$800.00K derived: sum of 3 quarters · filed 2023-03-22 | -$1.04M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$349.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$459.00K derived: sum of 2 quarters · filed 2022-11-08 | -$699.00K 10-Q · filed 2022-11-08 | -$857.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$350.00K 10-Q · filed 2022-08-15 | -$508.00K derived: sum of 3 quarters · filed 2022-08-15 | |
| 2021-03-31 | -$240.00K 10-Q · filed 2022-05-13 | -$398.00K derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | -$158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $75.00K 10-K · filed 2022-03-29 | ||
| 2020-09-30 | $233.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |